Treatment Action Group releases policy brief on US investments in tuberculosis research and development: A policy brief released by TAG today argues that decreasing US investment in TB research adds to the public health threat posed by TB to the United States and has already stalled the development of better and faster-acting treatment. Thanks to stagnant […]
The following is a guest post by Madhukar Pai of the McGill International TB Centre, Prashant Yadav of Montreal & Stephen M. Ross School of Business, and Ravi Anupindi of the University of Michigan, Ann Arbor. Whether it is mobile phone service or vacation travel, good businesses know that success depends on providing a complete and customer-centric solution. Should patients with tuberculosis […]
HIV
Researchers comparing measures in India study say yes The breakthrough represented by the development and WHO approval in 2010 of the GeneXpert rapid test to detect […]
Tuberculosis
Analysis shows TB may be sixth highest cause of under-five deaths; toll could be prevented with improved case-finding, diagnosis A study has produced the first estimates […]
Research & Development
Report gives evidence that neurological impacts of Zika go beyond effects on brain development By the time pediatric pathologists explored the cases reported in the August […]
Policy
Problems that included compromised vision, mobility, memory and concentration, as well as depression, anxiety and fatigue dogged Ebola survivors a year after their illnesses at rates […]